Zurich Cantonal Bank’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $435K | Sell |
|
|||||
|
2025
Q2 | $521K | Sell |
|
|||||
|
2025
Q1 | $437K | Sell |
|
|||||
|
2024
Q4 | $438K | Buy |
|
|||||
|
2024
Q3 | $388K | Buy |
|
|||||
|
2024
Q2 | $293K | Hold |
|
|||||
|
2024
Q1 | $241K | Hold |
|
|||||
|
2023
Q4 | $284K | Buy |
|
|||||
|
2023
Q3 | $264K | Sell |
|
|||||
|
2023
Q2 | $262K | Buy |
|
|||||
|
2023
Q1 | $236K | Buy |
|
|||||
|
2022
Q4 | $306K | Buy |
|
|||||
|
2022
Q3 | $319K | Hold |
|
|||||
|
2022
Q2 | $268K | Hold |
|
|||||
|
2022
Q1 | $412K | Sell |
|
|||||
|
2021
Q4 | $423K | Buy |
|
|||||
|
2021
Q3 | $386K | Buy |
|
|||||
|
2021
Q2 | $423K | Buy |
|
|||||
|
2021
Q1 | $248K | Buy |
|
|||||
|
2020
Q4 | $177K | Hold |
|
|||||
|
2020
Q3 | $82K | Hold |
|
|||||
|
2020
Q2 | $113K | Buy |
|
|||||
|
2020
Q1 | $35K | Buy |
|
|||||
|
2019
Q4 | $21K | Hold |
|
|||||
|
2019
Q3 | $18K | Hold |
|
|||||
|
2019
Q2 | $23K | Hold |
|
|||||
|
2019
Q1 | $50K | Hold |
|
|||||
|
2018
Q4 | $50K | Hold |
|
|||||
|
2018
Q3 | $47K | Hold |
|
|||||
|
2018
Q2 | $35K | Hold |
|
|||||
|
2018
Q1 | $29K | Hold |
|
|||||
|
2017
Q4 | $30K | Buy |
|
|||||
|
2017
Q3 | $9K | Hold |
|
|||||
|
2017
Q2 | $10K | Hold |
|
|||||
|
2017
Q1 | $15K | Hold |
|
|||||
|
2016
Q4 | $11K | Hold |
|
|||||
|
2016
Q3 | $8K | Hold |
|
|||||
|
2016
Q2 | $5K | Hold |
|
|||||
|
2016
Q1 | $5K | Hold |
|
|||||
|
2015
Q4 | $19K | Buy |
|
|||||
|
2015
Q3 | $8K | Buy |
|